Clinical trial
Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis Risk
NCT06224530 is registered in ClinicalTrials.gov with King's College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis Risk
- Lead sponsor
- King's College London
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 19, 2024
- Completion date
- August 30, 2026
- Enrollment
- 69 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
psychosis